Hedge funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September.
Juno Therapeutics Inc (NASDAQ:JUNO) jumped to a $67.22 per share pre-market high today, or 45.18% from the stock’s closing price yesterday, as the company announced that it has agreed to a ten-year ...
Peter Kolchinsky’s RA Capital Management filed its latest 13F with the Securities and Exchange Commission in February, and we’ve gone through the data to highlight three of its top new picks in the...
Andres Hove and Bong Koh’s VHCP Management revealed its top 3 biotech picks heading into 2015, in a 13F Form filed with the U.S. Securities and Exchange Commission last month.